Inventor · disambiguated record
Abdul Rasheed Mohammed
Also filed as: MOHAMMED ABDUL RASHEED
20 granted patents·4 pending applications·26 citations·filing 2009–2024
90Inventor score
Top patents by PatentIndex Score
24 records- 0189US9957257B2Amide compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted May 1, 2018·12 cites·9 claims
- 0278US9079894B2Heteroaryl compounds as 5-HT4 receptor ligandsNIROGI RAMAKRISHNA·Filed 2012·Granted Jul 14, 2015·5 cites·14 claims
- 0377US2024277690A1New uses of a 5-ht4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0477US2024293389A1Method of treating cognitive deficits associated with schizophreniaSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0575US10294217B2Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted May 21, 2019·1 cites·8 claims
- 0673US11040026B2Muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2017·Granted Jun 22, 2021·1 cites·16 claims
- 0773US10005711B2Process for large scale production of 1-isopropyl-3-{5-[1-(3-methoxypropyl)piperidin-4-YL]-[1,3,4]oxadiazol-2-YL}-1H-indazole oxalateSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Jun 26, 2018·2 cites·14 claims
- 0871US12285421B2Uses of a 5-HT4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2019·Granted Apr 29, 2025·0 cites·4 claims
- 0971US8735423B2Bicyclic compounds as α4β2 nicotinic acetylcholine receptor ligandsNIROGI RAMAKRISHNA·Filed 2009·Granted May 27, 2014·2 cites·8 claims
- 1068US10308620B2Muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Jun 4, 2019·1 cites·16 claims
- 1166US9636335B2Heteroaryl compounds as 5-HT4 receptor ligandsSUVEN LIFE SCIENCES LTD·Filed 2015·Granted May 2, 2017·1 cites·21 claims
- 1263US12338236B2Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disordersSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Jun 24, 2025·0 cites·5 claims
- 1363US8653071B2α4β2 neuronal nicotinic acetylcholine receptor ligandsNIROGI RAMAKRISHNA·Filed 2010·Granted Feb 18, 2014·1 cites·9 claims
- 1461US12391698B2Substituted piperidines and piperazines and methods for the treatment of CNS disordersSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Aug 19, 2025·0 cites·15 claims
- 1558US12275746B2Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Apr 15, 2025·0 cites·7 claims
- 1653US8598204B21,2-dihydro-2-oxoquinoline compounds as 5-HT4 receptor ligandsNIROGI RAMAKRISHNA·Filed 2009·Granted Dec 3, 2013·0 cites·6 claims
- 1751US2022409614A1Treating behavioral and psychological symptoms in dementia patientsSUVEN LIFE SCIENCES LTD·Filed 2020·Application pending·0 cites
- 1847US10973831B2Fluoropiperidine compounds as pure 5-HT 6 receptor antagonistsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Apr 13, 2021·0 cites·11 claims
- 1943US11278530B2Polycyclic amides as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Mar 22, 2022·0 cites·19 claims
- 2043US10603323B2Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitorsSUVEN LIFE SCIENCES LTD·Filed 2017·Granted Mar 31, 2020·0 cites·26 claims
- 2143US9951045B2Indazole compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Apr 24, 2018·0 cites·7 claims
- 2242US12156871B2Substituted azacycles as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Dec 3, 2024·0 cites·9 claims
- 2342US11234979B2Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Feb 1, 2022·0 cites·18 claims
- 2441US2019336509A1Triple combination of histamine-3 receptor inverse agonists, acetylcholinesterase inhibitors and nmda receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Abdul Rasheed Mohammed files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →